2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | 900-1000 |
Networking Rank (Reputation): | 900-1000 |
Networking Rank (Reputation): | 900-1000 |
2008 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 32.319.825 | 72.000 | 1 | ||
2019 | 0 | 14.994.551 | 619.313 | 1 | ||
2012 | 0 | 15.641.195 | 1.136.378 | 2 | ||
2011 | 0 | 3.974.000 | 100.800 | 1 |
Total number of partners: 103
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 100
Frequent / Rare Partner Ratio: 0.03
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-02-01 | Central Repository for Digital Pathology | BIGPICTURE | participant | 32.319.825 | 51 |
2019-01-01 | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | ONCOBIOME | participant | 14.994.551 | 18 |
2012-02-01 | Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer | RESPONSIFY | participant | 5.990.195 | 12 |
2012-02-01 | Enabling information re-Use by linking clinical REsearch and CAre | EURECA | participant | 9.651.000 | 20 |
2011-02-01 | Driving Excellence in Integrative Cancer Research through Innovative Biomedical Infrastructures | INTEGRATE | participant | 3.974.000 | 7 |